Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/02/2014US8900607 Clear, greaseless skin-care compositions
12/02/2014US8900605 Solid ivabradine-containing composition
12/02/2014US8900604 Fatty acid conjugates of quetiapine, process for making and using the same
12/02/2014US8900603 Local delivery of drugs from self assembled coatings
12/02/2014US8900602 Disintegrating particle composition and orally rapidly disintegrating tablet
12/02/2014US8900601 Permeable mixtures, methods and compositions for the skin
12/02/2014US8900579 Siglec-15 antibodies in treating bone loss-related disease
12/02/2014US8900576 Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
12/02/2014US8900571 Compositions and soft tissue replacement methods
12/02/2014US8900570 Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
12/02/2014US8900566 Hepatitis C virus inhibitors
12/02/2014US8900565 Indole derivatives as inhibitors of histone deacetylase
12/02/2014US8900562 Semi-fluorinated block copolymers for delivery of therapeutic agents
12/02/2014US8900560 Amide dendrimer compositions
12/02/2014US8900556 Hardenable thermally responsive compositions
12/02/2014US8900553 Oil and liquid silicone foamable carriers and formulations
11/2014
11/28/2014DE202014008500U1 Zusammensetzung enthaltend Rhodiola Rosea, Bacopa Monnieri und Pantothensäure für geistige Leistung. Composition containing Rhodiola Rosea, Bacopa monnieri and pantothenic acid for intellectual achievement.
11/28/2014DE202014003607U1 Immun - Naturgesundheitsprodukt Immune - Natural Health Product
11/27/2014US20140351963 MiRNAs Useful to Reduce Lung Cancer Tumorigenesis and Chemotherapy Resistance and Related Compositions and Methods
11/27/2014US20140351961 Compositions and methods for treatment of metastatic cancer
11/27/2014US20140350493 Dermal delivery device with in situ seal
11/27/2014US20140350482 Reconstitution device
11/27/2014US20140350464 Balloon catheter with a sirolimus coated catheter balloon for controlled release of sirolimus
11/27/2014US20140350293 Method for producing prodrug from amidoxime and n-hydroxyguanidine carboxylic acid esters
11/27/2014US20140350273 Pediatric uses of cabazitaxel
11/27/2014US20140350239 Pharmaceutical composition for relieving pain
11/27/2014US20140350122 Antimicrobial composition
11/27/2014US20140350120 Topical composition comprising an ingenol derivative and an oily solvent
11/27/2014US20140350119 Ophthalmic composition comprising geranylgeranylacetone
11/27/2014US20140350118 Topical compositions and methods for making and using same
11/27/2014US20140350117 Topical Scar Treatment Composition and Method of Using Same
11/27/2014US20140350114 Compositions comprising cyclohexylamines and aminoadamantanes
11/27/2014US20140350111 Methods for treatment and prophylaxis against hemorrhoids
11/27/2014US20140350110 CO-CRYSTALS OF TRAMADOL AND NSAIDs
11/27/2014US20140350109 N-Acetyl Beta Alanine Methods of Use
11/27/2014US20140350108 N-Acetyl Beta Alanine Methods of Use
11/27/2014US20140350107 Use of Pan-PPAR Agonists for Prevention and Treatment of Huntington's Disease and Tauopathies
11/27/2014US20140350106 Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same
11/27/2014US20140350105 Compositions and methods for producing elevated and sustained ketosis
11/27/2014US20140350104 Methods and compositions for reducing body fat and adipocytes
11/27/2014US20140350103 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/27/2014US20140350101 Gel compositions
11/27/2014US20140350097 Treatment of hypotension associated with hemodialysis
11/27/2014US20140350094 Solid composition containing catechins
11/27/2014US20140350093 Methods of treating or preventing insulin resistance and associated diseases and conditions
11/27/2014US20140350092 Method for inhibiting influenza virus infection
11/27/2014US20140350090 Microrna compounds and methods for modulating mir-122
11/27/2014US20140350087 Oncovector Nucleic Acid Molecules and Methods of Use
11/27/2014US20140350085 Novel sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
11/27/2014US20140350076 Induction of exon skipping in eukaryotic cells
11/27/2014US20140350070 Combination Therapy for MDS
11/27/2014US20140350069 Methods and agents to increase therapeutic dystrophin expression in muscle
11/27/2014US20140350064 Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof
11/27/2014US20140350063 Biotherapeutics for the treatment of infectious diseases
11/27/2014US20140350060 Methods of Administering Pirfenidone Therapy
11/27/2014US20140350054 Small-volume oral transmucosal dosage forms
11/27/2014US20140350053 Opioid formulations
11/27/2014US20140350052 Methods and Compositions for Reducing Serum Levels of Immunoglobulin E (IGE)
11/27/2014US20140350050 Pyridine compounds as inhibitors of kinase
11/27/2014US20140350049 Methods and pharmaceutical compositions for the treatment of darier disease
11/27/2014US20140350047 Isoform-selective inhibitors and activators of pde3 cyclic nucleotide phosphodiesterases
11/27/2014US20140350043 Fsh receptor antagonists
11/27/2014US20140350042 Methods for treating pruritus
11/27/2014US20140350041 Methods and Compositions for Treating a Disease Condition in a Subject
11/27/2014US20140350039 Combination
11/27/2014US20140350035 Combinations of medicaments, containing pde4-inhibitors and ep4-receptor- antagonists
11/27/2014US20140350034 Aminopyridine derivatives as plasma kallikrein inhibitors
11/27/2014US20140350033 Ant-ligands molecules and biological applications
11/27/2014US20140350029 Lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of at least one cns disorder
11/27/2014US20140350028 Pulmonary delivery of a fluoroquinolone
11/27/2014US20140350027 Pharmaceutical Compositions Comprising Imatinib and a Release Retardant
11/27/2014US20140350022 Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
11/27/2014US20140350021 Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases
11/27/2014US20140350020 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
11/27/2014US20140350019 Aniline derivatives, their preparation and their therapeutic application
11/27/2014US20140350018 Methods of Administering Monomethyl Fumarate and Prodrugs Thereof Having Reduced Side Effects
11/27/2014US20140350016 Potent and selective inhibitors of hepatitis c virus
11/27/2014US20140350014 Compounds for inhibiting the interaction of bcl2 with binding partners
11/27/2014US20140350010 Pyrazolopyrrolidine Compounds
11/27/2014US20140350009 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
11/27/2014US20140350008 2-heteroaryl carboxamides
11/27/2014US20140350006 Pyrazolopyridine Derivatives, Preparation Process Therefor And Therapeutic Use Thereof
11/27/2014US20140350005 D2 antagonists, methods of synthesis and methods of use
11/27/2014US20140350001 Pharmaceutical formulations of potassium atp channel openers and uses thereof
11/27/2014US20140349999 Methods for treating antipsychotic-induced weight gain
11/27/2014US20140349996 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
11/27/2014US20140349994 Novel 2-Amino-4,5,6,8-Tetrahydropyrazolo[3,4-b]Thiazolo [4,5-d]Azepine Derivatives and Their Use as Allosteric Modulators of Metabotropic Glutamate Receptors
11/27/2014US20140349993 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
11/27/2014US20140349990 Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease
11/27/2014US20140349989 Compounds and therapeutic uses thereof
11/27/2014US20140349988 Organonitro thioether compounds and medical uses thereof
11/27/2014US20140349985 Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, prepartion method thereof, and use thereof
11/27/2014US20140349984 Methods for the treatment of a traumatic central nervous system injury
11/27/2014US20140349983 Method for treating ulcerative colitis
11/27/2014US20140349982 Methods of treating ulcerative colitis
11/27/2014US20140349981 Topical pharmaceutical compositions comprising bexarotene and a corticosteroid
11/27/2014US20140349980 Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
11/27/2014US20140349979 Stabilized modified release vitamin d formulation and method of administering same
11/27/2014US20140349978 Salicylic Acid Gel
11/27/2014US20140349976 Co-administration of pimavanserin with other agents
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 7860